Integrated Filing — IndAS



General information about company

Scrip Code 506109
NSE Symbol GENESYS
MSEI Symbol NOTLISTED
ISIN INE727B01026
Name of company GENESYS INTERNATIONAL CORPORATION LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 29-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Geographical information system
Start date and time of board meeting 29-05-2026   17:00:00
End date and time of board meeting 29-05-2026   20:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 14-02-2025
Indicate Company website link for updated RPT policy of the Company www.igenesys.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No such default



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 7,844.10 27,230.11
Other income 357.70 2,010.58
Total income 8,201.80 29,240.69
2 Expenses
(a) Cost of materials consumed 3,763.03 10,604.68
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 1,529.74 6,358.94
(e) Finance costs 335.09 1,247.53
(f) Depreciation, depletion and amortisation expense 1,047.71 3,903.89
(f) Other Expenses
1 Other Expenses 1,252.05 3,219.07
Total other expenses 1,252.05 3,219.07
Total expenses 7,927.62 25,334.11
3 Total profit before exceptional items and tax 274.18 3,906.58
4 Exceptional items 0.00 (509.62)
5 Total profit before tax 274.18 3,396.96
6 Tax expense
7 Current tax 301.69 1,155.77
8 Deferred tax 178.86 186.98
9 Total tax expenses 480.55 1,342.75
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (206.37) 2,054.21
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (206.37) 2,054.21
17 Other comprehensive income net of taxes 54.68 75.16
18 Total Comprehensive Income for the period (151.69) 2,129.37
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 2,089.52 2,089.52
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve 0.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.49 4.95
Diluted earnings (loss) per share from continuing operations -0.49 4.95
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.49 4.95
Diluted earnings (loss) per share from continuing and discontinued operations -0.49 4.95
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to the Statement of audited standalone financial results for the quarter and year ended 31 March 2026 The audited Standalone financial results of Genesys International Corporation Limited GICL the Company have been prepared in accordance with the Indian Accounting Standards (Ind AS), notified under Section 133 of the Companies Act, 2013, as amended, read with relevant rules there under and other accounting principles generally accepted in lndia and in compliance with Regulation 33 of the Securities and Exchange Board of lndia (Listing Obligations and Disclosure Requirements) 2015 as amended The audited standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 29 May 2026. These audited standalone financial results have been subjected to audit by the statutory auditors of the Company and they have expressed an unmodified opinion on these audited standalone financial results. The above audited financial results of the Company are available on the Company's website www.igenesys.com.com and stock exchanges websites, BSE www.bseindia.com and NSE www.nseindia.com where the shares of the Company are listed On 17th May 2025 the Company has, by way of Qualified Institutional Placement (QIP) in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended and section 42 and 62 of the Companies Act, 2013 alloted 1739625 equity shares of face value of Rs 5 per share at a price of Rs 632.32 per share, aggregating to Rs 11,000 lakhs. The funds raised by the Company pursuant to QIP have been partially utilized in accordance with the Use of Proceeds mentioned in the placement document of QIP for the year ended 31 March 2026 and unutilized balances as at 31 March 2026 have been temporarily invested The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures in respect of the full financial year and the unaudited published year to date figures up to the nine months ended 31 December 2025 and 31 December 2024 respectively which were subject to limited review by the statutory auditors The Company operates only in one Primary Segment ie GIS based services hence disclosure as per IND AS 108 Operating Segment is not required Pursuant to the notification issued by Ministry of Labour and Employment multiple existing labour legislations have been consolidated into a unified framework comprising four labour codes collectively referred to as the New Labour Codes which became effective from November 21 2025. The Company has reassessed its employee benefit obligations in accordance with the new definition of wages. Accordingly, an incremental liability of Rs. 509.62 Lakhs (Gratuity – 356.35 Lakhs and Leave Encashment – 153.26 Lakhs) has been recognised as an Exceptional item for the quarter ended 31 December and year ended March 31 2026. The management will continue to evaluate the impact of the rules notified by the central government/ state government post 31 March 2026 and consider the appropriate accounting effect in the relevant period as needed Previous period figures have been re-grouped re-classified wherever necessary



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 5,378.77
Capital work-in-progress 55.73
Investment property
Goodwill 0.00
Other intangible assets 9,610.13
Intangible assets under development 10,988.59
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 13,647.16
Trade receivables, non-current
Loans, non-current 23.00
Other non-current financial assets
1 Other financial assets 3,585.45
Total of other non-current financial assets 3,585.45
Total non-current financial assets 17,255.61
Deferred tax assets (net) 972.83
Other non-current assets
1 Other non current assets 519.41
Total of other non-current assets 519.41
Total non-current assets 44,781.07
2 Current assets
Inventories 0.00
Current financial asset
Current investments 0.00
Trade receivables, current 14,342.81
Cash and cash equivalents 821.20
Bank balance other than cash and cash equivalents 9,468.56
Loans, current 392.35
Other current financial assets
Total of other current financial assets 30,397.07
Total current financial assets 55,421.99
Current tax assets (net) 253.67
Other current assets
1 Other current assets 741.96
Total of other current assets 741.96
Total current assets 56,417.62
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,01,198.69
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,089.52
Other equity 72,856.61
Total equity attributable to owners of parent 74,946.13
Non controlling interest
Total equity 74,946.13
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 472.64
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease Liabilities 710.54
Total of other non-current financial liabilities 710.54
Total non-current financial liabilities 1,183.18
Provisions, non-current 1,307.79
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 2,490.97
Current liabilities
Current financial liabilities
Borrowings, current 15,544.77
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 651.38
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 3,160.09
Total Trade payable 3,811.47
Other current financial liabilities
1 Lease liabilities 565.89
2 Other financial liabilities 2,380.14
Total of other current financial liabilities 2,946.03
Total current financial liabilities 22,302.27
Other current liabilities 289.11
1 Other current liabilities 289.11
Total of other current liabilities 289.11
Provisions, current 383.69
Current tax liabilities (Net) 786.52
Deferred government grants, Current
Total current liabilities 23,761.59
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 26,252.56
Total equity and liabilites 1,01,198.69
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit plans (net of taxes) 54.68 75.16
Total Amount of items that will not be reclassified to profit and loss 54.68 75.16
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 54.68 75.16



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 3,396.96
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,247.53
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current 4,378.14
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (57.43)
Adjustments for decrease (increase) in other non-current assets 64.42
Adjustments for other financial assets, non-current (604.98)
Adjustments for other financial assets, current (9,158.21)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 192.19
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (463.79)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 3,903.89
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 248.58
Adjustments for provisions, non-current 361.42
Adjustments for other financial liabilities, current 33.74
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (24.31)
Adjustments for dividend income 0.00
Adjustments for interest income 664.93
Adjustments for share-based payments 174.96
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 585.22
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 216.44
Net cash flows from (used in) operations 3,613.40
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,970.87
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 1,642.53
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 96.39
Purchase of property, plant and equipment 1,466.34
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 2,230.83
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 2,209.65
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 591.49
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (9,627.54)
Net cash flows from (used in) investing activities (14,846.48)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 10,353.14
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 189.43
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 6,019.63
Repayments of borrowings 958.18
Payments of lease liabilities 569.36
Dividends paid 0.00
Interest paid 1,121.21
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 13,913.45
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 709.50
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 709.50
Cash and cash equivalents cash flow statement at beginning of period 111.70
Cash and cash equivalents cash flow statement at end of period 821.20





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 17-05-2026
Amount Raised 11,000.00
Report filed for Quarter ended 31-03-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review None
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Setting up of data centre No 1,770.50 0.00 0.00 0.00
2 Development of tech platform No 2,574.22 0.00 141.98 0.00
3 Creation/updation of map content No 1,865.16 0.00 0.00 0.00
4 Building sensor capacity No 1,056.83 0.00 0.00 0.00
5 Strengthening information technology infrastructure No 983.34 0.00 0.00 0.00
6 General corporate purposes No 2,049.15 0.00 2,045.00 0.00
7 Issue Expenses No 700.80 0.00 646.98 0.00


Signatory Details

Name of signatory Kushal Jain
Designation of person Company Secretary and Compliance Officer
Place Mumbai
Date 29-05-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Remuneration Remuneration is as per the Companies Act 2013 and Shareholders Approval 63.00 2.00 0.00
2 Genesys International Corporation Limited Mr. Manish Patel Non executive Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 0.35 0.00 0.00
3 Genesys International Corporation Limited Ms. Bharti Sinha Non executive Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 0.70 0.00 0.00
4 Genesys International Corporation Limited Mr. Ajay Harish Aggarwal Non executive Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 0.70 0.00 0.00
5 Genesys International Corporation Limited Dr. Yogita Shukla Non executive Non Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 0.00 0.00 0.00
6 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Sitting Fees As per the Companies Act 2013 0.50 0.00 0.00
7 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Consultancy Fees 60.00 approved by the Audit committee 30.00 5.50 4.50
8 Genesys International Corporation Limited Mrs. Sunita Hemrajani Relative of Director Any other transaction Consultancy Fees 60.00 approved by the Audit committee 30.00 5.66 4.34
9 Genesys International Corporation Limited AddGeo Foundation Company in which Common Directorship Any other transaction Consultancy Fees 12.00 approved by the Audit committee 1.93 0.00 0.00
10 Genesys International Corporation Limited Mr. Kushal Jain Company Secretary and Compliance Officer Remuneration not applicable 11.54 1.62 1.63 Textual Information(1)
11 Genesys International Corporation Limited Mr. Kushal Jain Company Secretary and Compliance Officer Any other transaction ESOP Expense not applicable 3.40 0.00 0.00 Textual Information(2)
12 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Remuneration not applicable 62.27 6.99 6.31
13 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Any other transaction advance adjusted 10.00 approved by the Audit committee 2.02 4.43 2.41 Advance 0 3 years Unsecured Salary advance
14 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Any other transaction ESOP Expense not applicable 1.49 0.00 0.00
15 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Any other transaction Loan Received 2,500.00 approved by the Audit committee 985.00 1,240.00 2,225.00 Loan 0 Repayable on demand Unsecured Working capital
16 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Any other transaction Loan repaid 2,500.00 approved by the Audit committee 0.00 1,240.00 2,225.00 Loan 0 Repayable on demand Unsecured Working capital
17 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Loan Received 2,500.00 approved by the Audit committee 950.00 1,100.00 2,050.00 Loan 0 Repayable on demand Unsecured Working capital
18 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Loan repaid 2,500.00 approved by the Audit committee 0.00 1,100.00 2,050.00 Loan 0 Repayable on demand Unsecured Working capital
19 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction Interest payable 237.60 approved by the Audit committee 31.97 55.24 0.59 Loan 12.00 Repayable on demand Unsecured Working capital
20 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction loan repaid 1,980.00 approved by the Audit committee 750.00 750.00 400.00 Loan 12.00 Repayable on demand Unsecured Working capital
21 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Investment not applicable 0.00 7,399.40 7,399.40
22 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Loan not applicable 460.94 583.05 388.75 Loan 8.00 3 years Unsecured Working capital
23 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Any other transaction loan returned not applicable 668.11 583.05 388.75 Loan 8.00 3 years Unsecured Working capital
24 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Interest received not applicable 25.09 7.52 24.11
25 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Any other transaction Project expense not applicable 510.22 307.01 285.51
26 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Sale of goods or services not applicable 70.41 2,228.87 2,225.78
27 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Investment not applicable 0.00 312.37 312.37
28 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Any other transaction Provision for impairment of Investments 8,569.79 approved by the Audit committee 0.00 8,569.79 8,569.79
29 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Investment not applicable 0.00 14,505.18 14,505.18
30 Genesys International Corporation Limited Late Mrs. Saroja Siraj Malik Whole-time Director Remuneration Remuneration is as per the Companies Act 2013 and Shareholders Approval 0.00 0.32 0.32
31 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction Loan received 1,980.00 approved by the Audit committee 400.00 750.00 400.00 Loan 12.00 Repayable on demand Unsecured Working capital
32 Genesys International Corporation Limited Ventura Guaranty Ltd Common director Any other transaction Loan received 2,000.00 approved by the Audit committee 900.00 0.00 0.00 Loan 12.500 Repayable on demand Unsecured Working capital
33 Genesys International Corporation Limited Ventura Guaranty Ltd Common director Any other transaction Loan repaid 2,000.00 approved by the Audit committee 900.00 0.00 0.00 Loan 12.500 Repayable on demand Unsecured Working capital
34 Genesys International Corporation Limited Ventura Guaranty Ltd Common director Any other transaction Interest payable approved by the Audit committee 11.31 0.00 0.00 Loan 12.500 Repayable on demand Unsecured Working capital
Total value of transaction during the reporting period 6,870.95



Text Block

Textual Information(1) Company Secretary with effect from 1st June 2025
Textual Information(2) Company Secretary with effect from 1st June 2025